COVID-19

See how art collector turned immunologist James Crowe combines abstract thinking with game-changing technology to prevent infectious disease. Read More

Vanderbilt is committed to keeping the university community safe and informed. Information, resources and avenues of support are now available on the Health and Wellness website for people living with or caring for someone with Long COVID. Read More

Reporting Nov. 6 in Cell Reports Medicine, Ivelin Georgiev, PhD, and colleagues demonstrated that antibodies isolated from children’s blood samples displayed high levels of neutralization and potency against variants of the COVID-19 virus, SARS-CoV-2, even when the children had not previously been exposed to or vaccinated against those variants. Read More

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes. Read More

A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective. Read More

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading. Read More

Two Vanderbilt faculty who conducted translational research have received the distinction of Best Invention of 2022 from TIME magazine. TIME’s Best Inventions of 2022 Cover “These winning innovations exemplify the transformative potential of university research when it aims to solve society’s most urgent problems, and when universities partner with the broader innovation ecosystem to bring... Read More

Two Vanderbilt faculty who conducted translational research have received the distinction of Best Invention of 2022 from TIME magazine. TIME’s Best Inventions of 2022 Cover “These winning innovations exemplify the transformative potential of university research when it aims to solve society’s most urgent problems, and when universities partner with the broader innovation ecosystem to bring... Read More

The School of Medicine Basic Sciences Dean’s Lecture featured renowned immunologist, virologist, and alumnus Dr. Barney S. Graham. In his talk, “Reflections on Pandemics and the Future of Medicine,” Graham discussed his early research experiences leading up to his seminal work on the first experimental COVID-19 vaccines, along with his observations on the pandemic and hopes for the future of medicine. Read More

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. Read More

Globally, at least 60% of countries proposed remote learning options that rely only on online platforms, but approximately 47% of students cannot connect to the internet from their homes. This Insights report analyzes factors affecting perceptions of government-provided distance learning during the pandemic. Read More

New Vanderbilt research explores the economic effects of pandemic-related migration patterns on municipal bonds. Read More

Moderna’s COVID-19 vaccine is safe and generates robust immune responses in children ages 6 to 11 years, a national clinical trial co-led by C. Buddy Creech, MD, MPH, has found. Read More

Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.   Read More

In the midst of working toward her master's of science in nursing, military nurse and mother of 10 Stacy Rokas was deployed to the front lines of the COVID-19 pandemic. That’s when her nursing school instructors became her lifeline in battling the new and evolving disease. Read More

Vanderbilt's James Crowe Jr., MD, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19. Read More

Peter Buerhaus, PhD, FAAN, FAANP(h), a renowned researcher who studies the health care workforce and economy will share his expertise on the future of nursing, health equity and the relationship balance between nurses, leadership and educators. He will be the inaugural speaker in a new Leadership Lecture Series presented by the Vanderbilt University School of... Read More

Concerns about strife in a country far from home are adding worries to a generation already on edge from navigating changes in everyday life due to the COVID-19 pandemic. Here are some ideas for how to help. Read More

Some of Vanderbilt University’s leading experts on vaccines, infectious disease and public health came together for a special panel discussion on March 10 to talk about the future of the COVID-19 pandemic. The virtual event, “The COVID Conundrum: What’s Next,” was hosted by the Chancellor’s Lecture Series in partnership with the Vanderbilt School of Medicine Basic Sciences. Read More

New research from Vanderbilt Business highlights the importance of families, social workers, and chaplains to patient care. Read More